These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 261563)

  • 1. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A
    Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H; Scott JG; Movat HZ; Scialla SJ
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factor XII deficiency - Hageman trait. Additional diagnostic procedures].
    Martinić P
    Bilt Hematol Transfuz; 1979; 7(2-3):151-8. PubMed ID: 263755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor-XII congenital deficiency. A new family study.
    Lucia JF; Ercoreca L; Torres M; Giralt M; Raichs A
    Thromb Haemost; 1979 Oct; 42(3):1009-17. PubMed ID: 505391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities.
    Patrassi GM; Martinelli S; Vianello C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):644-54. PubMed ID: 6184289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Moderate deficiency of Factor XII associated with postoperative deep venous thrombosis].
    Cornudella R; Puente F; Hortells JL; Gutiérrez M
    Sangre (Barc); 1989 Apr; 34(2):144-6. PubMed ID: 2756451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma factor XII (Hageman factor) in disease states (author's transl)].
    Ichinose A; Maruyama I; Imaguma M; Sonoda T; Igata A
    Rinsho Ketsueki; 1981 Aug; 22(8):1232-6. PubMed ID: 7328776
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factor XII (HAGEMAN FACTOR)].
    Kase F; Klír P; Pospísil J; Poucková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hageman factor (factor XII) in health and diseases.
    Saito H
    Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1460-5. PubMed ID: 7342648
    [No Abstract]   [Full Text] [Related]  

  • 15. [The mechanism of activation of kallikrein-kinin system in the plasma of patients with atopic allergic diseases].
    Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Iarovaia GA
    Vopr Med Khim; 1988; 34(6):89-94. PubMed ID: 3238945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clotting defect in a factor XII-deficient kindred.
    Chistolini A; Mazzucconi MG; Motta M; Solinas S; Tirindelli MC; Mariani G
    Ric Clin Lab; 1985; 15(3):241-5. PubMed ID: 3853270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic gout in Hageman factor (Factor XII) deficiency.
    Green D; Arsever CL; Grumet KA; Ratnoff OD
    Arch Intern Med; 1982 Aug; 142(8):1556-7. PubMed ID: 7103639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved methods to assay contact activation.
    Soulier JP; Gozin D
    Adv Biosci; 1978 Jul; 17():271-80. PubMed ID: 755703
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of various infusion media and solutions on the kallikrein-kinin system of human plasma].
    Dotsenko VL; Morozova NA; Iarovaia GA
    Vopr Med Khim; 1985; 31(4):116-21. PubMed ID: 3931350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
    Dors DM; Nuijens JH; Huijbregts CC; Hack CE
    Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.